High throughput screening of populations carrying naturally occurring mutations

US9745627B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9745627-B2
Application numberUS-201715434801-A
CountryUS
Kind codeB2
Filing dateFeb 16, 2017
Priority dateSep 29, 2005
Publication dateAug 29, 2017
Grant dateAug 29, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Efficient methods are disclosed for the high throughput identification of mutations in genes in members of mutagenized populations. The methods comprise DNA isolation, pooling, amplification, creation of libraries, high throughput sequencing of libraries, preferably by sequencing-by-synthesis technologies, identification of mutations and identification of the member of the population carrying the mutation and identification of the mutation.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of detecting a genetic variation, comprising: (a) tagging each of a plurality of nucleic acid molecules using a plurality of tags, each tag comprising a tag sequence, such that a subset of the nucleic acid molecules in the plurality have the same tag sequence, to generate a set of tagged nucleic acid molecules; (b) subjecting the set of tagged nucleic acid molecules to amplification to generate amplification products; (c) sequencing the amplification products with a multi-fold redundancy to generate sequence reads; and (d) aligning the sequence reads to identify the genetic variation. 2. The method of claim 1 , wherein the genetic variation is naturally occurring. 3. The method of claim 2 , wherein the genetic variation is a single nucleotide polymorphism (SNP), a small insertion or a deletion, or a variation in microsatellite repeat number. 4. The method of claim 1 , wherein the nucleic acid molecules are human derived. 5. The method of claim 1 , wherein the nucleic acid molecules are genomic DNA molecules. 6. The method of claim 1 , wherein both ends of each of the plurality of nucleic acid molecules are tagged. 7. The method of claim 1 , wherein the multi-fold redundancy comprises a redundancy of at least 2. 8. The method of claim 1 , wherein the multi-fold redundancy permits distinction between a sequencing error and a genetic variation. 9. The method of claim 1 , wherein the identification of the genetic variation comprises identifying a sequence change multiple times. 10. The method of claim 1 , wherein the identification is performed in silico. 11. The method of claim 1 , further comprising preparing the nucleic acid molecules for sequencing by ligating adaptors to create a library of single stranded DNA. 12. The method of claim 1 , wherein the sequencing is performed using high-throughput sequencing. 13. The method of claim 1 , wherein the sequencing is bi-directional sequencing. 14. The method of claim 1 , wherein the sequencing is sequencing-by-synthesis. 15. The method of claim 1 , wherein the sequencing is performed on a solid support. 16. The method of claim 1 , wherein the sequencing comprises detecting a light signal indicative of a sequencing reaction. 17. The method of claim 1 , wherein aligning comprises comparing the sequence reads to a reference sequence. 18. The method of claim 1 , wherein aligning comprises comparing the sequence reads to a consensus sequence. 19. The method of claim 1 , wherein the genetic variation is identified without the use of an enzyme which recognizes and cuts single nucleotide sequence mismatches and without performing heteroduplex analysis. 20. The method of claim 1 , wherein the nucleic acid molecules are tagged using amplification or ligation. 21. The method of claim 1 , wherein the alignment is performed using a computer program. 22. A method of detecting a genetic variation as compared to a reference sequence, comprising: (a) tagging each of a plurality of nucleic acid molecules using a plurality of tags, each tag comprising a tag sequence, such that a subset of the nucleic acid molecules in the plurality have the same tag sequence, to generate a set of tagged nucleic acid molecules, each of the tagged nucleic acid molecules comprising a tag at each end; (b) subjecting the set of tagged nucleic acid molecules to amplification to generate amplification products; (c) performing high-throughput sequencing-by-synthesis of the amplification products of step (a) to generate a set of sequence reads; (d) aligning the set of sequence reads using the reference sequence to identify the genetic variation.

Assignees

Inventors

Classifications

  • C12Q1/6874Primary

    involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • Plant traits · CPC title

  • Common amplification features · CPC title

  • for detection of mutation or polymorphism · CPC title

  • Allele-specific amplification · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9745627B2 cover?
Efficient methods are disclosed for the high throughput identification of mutations in genes in members of mutagenized populations. The methods comprise DNA isolation, pooling, amplification, creation of libraries, high throughput sequencing of libraries, preferably by sequencing-by-synthesis technologies, identification of mutations and identification of the member of the population carrying t…
Who is the assignee on this patent?
Keygene Nv
What technology area does this patent fall under?
Primary CPC classification C12Q1/6874. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).